Los Angeles, CA, United States of America

Diptiman Choudhury

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diptiman Choudhury: Innovator in Cancer Prognosis Technology

Introduction

Diptiman Choudhury is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer prognosis through his innovative technologies. His work focuses on developing methods and devices that can aid in the early detection and monitoring of various types of cancer.

Latest Patents

Diptiman Choudhury holds a patent for a device, system, and method for cancer prognosis and its uses. This patent, which is aimed at measuring or detecting cysteine and/or methionine metabolite levels in a sample from a subject, has important implications for cancer diagnosis. The invention includes various embodiments that concern prognosing or diagnosing cancers such as prostate, colon, ovarian, or breast cancer. It also addresses predicting the risk of cancer recurrence and monitoring conditions like cystinuria or cystine stone disease. He has 1 patent to his name.

Career Highlights

Choudhury is affiliated with Cedars-Sinai Medical Center, where he continues to work on advancing medical technologies. His role at this prestigious institution allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Neil A. Bhowmick and Michael John Baker. Their collaborative efforts enhance the research and development of innovative solutions in cancer prognosis.

Conclusion

Diptiman Choudhury's work exemplifies the intersection of technology and healthcare, particularly in the fight against cancer. His contributions are paving the way for more effective diagnostic tools and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…